Search
vatinoxan (Zenalpha)
Indications:
- in combination with medetomidine as a sedative & analgesic in dogs, during clinical examination & procedures
Mechanism of action:
- alpha-2 adrenergic receptor antagonist
- vatinoxan reduces negative cardiovascular effects of medetomidine
Interactions
drug adverse effects of antihypertensive agents
General
alpha-2 adrenergic receptor antagonist
Database Correlations
PUBCHEM cid=182976
References
- FDA approves new combination injection for sedation and pain relief in dogs.
https://www.dvm360.com/view/fda-approves-new-combination-injection-for-sedation-and-pain-relief-in-dogs
Component-of
medetomidine/vatinoxan